Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Maurer Michael TCHIEF COMMERCIAL OFFICER | Grant or award | A | — 80.0K sh | May 28, 2026 |
| 9 | Morrell MarthaCHIEF MEDICAL OFFICER | Tax withholding | F | $6,107 358 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Blomquist Denise L.Chief Accounting Officer | Option exercise | M | — 1,621 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Lipman PaulChief Revenue Officer | Option exercise | M | $26K 100.0K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Arias Juan CarlosSee Remarks | Tax withholding | F | $4,872 348 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Chapman Jeffrey MDirector | Grant or award | A | — 1,532 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Kozlov HershDirector | Grant or award | A | — 3,600 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Marinaro MichaelEVP, Pres MedSurg and Americas | Option exercise | M | — 17.1K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Clayton Natasha LauretteSee Remarks | Tax withholding | F | $27K 1,961 sh | May 28, 2026 traded May 27, 2026 |
| 9 | McEntee James J IIIDirector | Grant or award | A | — 3,600 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Walter Matthew R.SVP, Chief HR Officer | Option exercise | M | — 8,449 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Bell John IrvingDirector | Grant or award | A | — 27.5K sh | May 28, 2026 traded May 27, 2026 |
| 9 | Lahr TroyEVP & Chief Financial Officer | Grant or award | A | — 10.0K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $292K 1,438 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $335K 1,652 sh | May 28, 2026 traded May 26, 2026 |
| 8 | Tray ThomasPrincipal Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $200K 2,051 sh | May 28, 2026 traded May 26, 2026 |
| 8 | Sousa Mauad BrunoDirector | Other acquisition or disposition | J | — 18.1K sh | May 28, 2026 traded May 27, 2026 |
| 8 | Sousa Mauad BrunoDirector | Other acquisition or disposition | J | — 18.1K sh | May 28, 2026 traded May 27, 2026 |
| 8 | Congdon David SDirector, Executive Chairman | Gift | G | — 295.7K sh | May 28, 2026 traded May 27, 2026 |
| 8 | Musser ForySenior VP, Development | Option exercise | M | $210K 266.3K sh | May 28, 2026 traded May 26, 2026 |
| 8 | Musser ForySenior VP, Development | Option exercise | M | $185K 233.7K sh | May 28, 2026 traded May 27, 2026 |
| 6 | Beck PeterDirector, CEO | Derivative conversion | C | — 5.00M sh | May 28, 2026 traded May 26, 2026 |
| 5 | Lentz DanielCFO & COO | Open-market sale · 10b5-1 plan | SELL | $20K 6,840 sh | May 28, 2026 traded May 26, 2026 |
| 5 | Bonnett Derek AChief Risk Officer | Grant or award | A | — 1,756 sh | May 28, 2026 traded May 27, 2026 |
| 5 | Espinoza OctavioChief Financial Officer | Option exercise | M | $51K 972 sh | May 28, 2026 traded May 27, 2026 |
| 5 | Lipman PaulChief Revenue Officer | Option exercise | M | $5,200 20.0K sh | May 28, 2026 traded May 27, 2026 |
| 5 | Juskie Jo AnnSVP | Tax withholding | F | $48K 136 sh | May 28, 2026 traded May 26, 2026 |
| 5 | Bonnett Derek AChief Risk Officer | Option exercise | M | — 2,151 sh | May 28, 2026 traded May 26, 2026 |
| 5 | Schwab-Pomerantz CarolynDirector | Grant or award | A | — 3,977 sh | May 28, 2026 traded May 26, 2026 |
| 5 | Lipman PaulChief Revenue Officer | Option exercise | M | — 20.0K sh | May 28, 2026 traded May 27, 2026 |
| 4 | Kuykendall AnneSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $115K 2,100 sh | May 28, 2026 traded May 26, 2026 |
| 4 | Kuykendall AnneSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $87K 1,600 sh | May 28, 2026 traded May 26, 2026 |
| 2 | Espinoza OctavioChief Financial Officer | Option exercise | M | $49K 764 sh | May 28, 2026 traded May 27, 2026 |
| 2 | Espinoza OctavioChief Financial Officer | Option exercise | M | — 972 sh | May 28, 2026 traded May 27, 2026 |
| 2 | Beck PeterDirector, CEO | Derivative conversion | C | — 5.00M sh | May 28, 2026 traded May 26, 2026 |
| 2 | Espinoza OctavioChief Financial Officer | Option exercise | M | — 764 sh | May 28, 2026 traded May 27, 2026 |
| 2 | Cohn MatthewDirector | Grant or award | A | — 2,250 sh | May 28, 2026 traded May 27, 2026 |
| 1 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $92K 8,726 sh | May 28, 2026 traded May 26, 2026 |
| 1 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $63K 5,974 sh | May 28, 2026 traded May 27, 2026 |
| 1 | Sakamoto Ryan T.EVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $9,245 2,914 sh | May 28, 2026 traded May 26, 2026 |